Literature DB >> 34817668

ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway.

Min Yang1, Xi-Rong Gao2, Yan-Ni Meng1, Fang Shen3, Yan-Ping Chen4.   

Abstract

PURPOSE: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects newborns who need oxygen therapy, and high-concentration oxygen therapy may cause neonatal morbidity and mortality in newborns. E26 oncogene homologue 1 (ETS1) and transglutaminase 2 (TGM2) have been reported to be associated with lung cell injury. However, the mechanism of ETS1 in regulating BPD is still unclear.
METHODS: Hyperoxia-induced A549 cells to simulate hyperoxia-induced alveolar epithelial cell injury. MTT assays and colony formation assays were performed to investigate the proliferation of A549 cells. Flow cytometry was carried out to quantify the apoptosis of A549 cells. The expression levels of ETS1 and TGM2 were quantified by qRT-PCR. The protein expression levels of ETS1, TGM2, β-catenin, c-Jun and MET were measured by western blot. Overexpression of ETS1, overexpression of TGM2, overexpression of ETS1 with downregulation of TGM2 and overexpression of TGM2 with inhibition of Wnt/β-catenin pathway were performed to investigate the role of ETS1, TGM2 and Wnt/β-catenin pathways in hyperoxia-induced alveolar epithelial cell injury.
RESULTS: Hyperoxia decreased the proliferation and promoted the apoptosis of cells in a time-dependent manner. Moreover, overexpression of ETS1 rescued the effect of hyperoxia on proliferation and apoptosis. In addition, overexpression of TGM2 participated in the regulation of hyperoxia-induced proliferation and apoptosis. ETS1 regulated hyperoxia-induced alveolar epithelial cell injury through the Wnt/β-catenin pathway via TGM2.
CONCLUSION: ETS1 ameliorates hyperoxia-induced alveolar epithelial cell injury through the TGM2-mediated Wnt/β-catenin pathway.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bronchopulmonary dysplasia; ETS1; TGM2

Mesh:

Substances:

Year:  2021        PMID: 34817668     DOI: 10.1007/s00408-021-00489-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  5 in total

1.  Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.

Authors:  Chang-Min Choi; Se-Jin Jang; Seong-Yeol Park; Yong-Bock Choi; Jae-Heon Jeong; Dae-Seok Kim; Hyun-Kyoung Kim; Kang-Seo Park; Byung-Ho Nam; Hyeong-Ryul Kim; Soo-Youl Kim; Kyeong-Man Hong
Journal:  Mol Cancer       Date:  2011-09-24       Impact factor: 27.401

2.  Activation of mas restores hyperoxia-induced loss of lung epithelial barrier function through inhibition of apoptosis.

Authors:  Amal Abdul-Hafez; Tarek Mohamed; Bruce D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2019-07-18

3.  Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells.

Authors:  Huaping Huang; Tangying Li; Mingjing Chen; Feng Liu; Haifeng Wu; Jie Wang; Jialiang Chen; Xi Li
Journal:  Cell Mol Biol Lett       Date:  2018-11-27       Impact factor: 5.787

4.  Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer.

Authors:  Hyun Ee Yim; Jang-Hee Kim; Mi Sun Ahn; Yongsik Jung; Jin Roh; So Hyun Park; Tae-Gyu Kim; Jin-Hyuk Choi; Seok Yun Kang
Journal:  Front Oncol       Date:  2021-03-01       Impact factor: 6.244

5.  Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis.

Authors:  Jian Gao; Shuang Peng; Xinni Shan; Guoliang Deng; Lihong Shen; Jian Sun; Chunhong Jiang; Xiaoling Yang; Zhigang Chang; Xinchen Sun; Fude Feng; Lingdong Kong; Yanhong Gu; Wenjie Guo; Qiang Xu; Yang Sun
Journal:  Cell Death Dis       Date:  2019-12-20       Impact factor: 8.469

  5 in total
  2 in total

Review 1.  Effects of Antioxidants in Human Milk on Bronchopulmonary Dysplasia Prevention and Treatment: A Review.

Authors:  Xianpeng Yang; Shanyu Jiang; Xianhui Deng; Zichen Luo; Ailing Chen; Renqiang Yu
Journal:  Front Nutr       Date:  2022-07-18

2.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.